“Real-World Safety of Spesolimab in Generalized Pustular Psoriasis: Evidence from an Expanded Access Program in Argentina”. 2024. SKIN The Journal of Cutaneous Medicine 8 (6): s487. https://doi.org/10.25251/skin.8.supp.487.